BioSpace News Archive

Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that an abstract for its ongoing Phase II study of oral paclitaxel and encequidar (Oral Paclitaxel; formerly known as Oraxol),

The U.S. Food and Drug Administration today granted marketing authorization for a new device indicated to provide continuous hemodialysis or hemofiltration therapy to critically ill pediatric patients weighing between 2.5 and 10 kilograms (or 5.5 to 22 pounds).

Adds New Data to Comprehensive Online Resource Center Bloomberg Philanthropies, Stavros Niarchos Foundation Provide Critical Funding to Develop and Expand This Work COVID-19 Resource Center Website Now Tracking U.S. Testing Efforts and Providing Expert Analysis.

Key Biologics and Astarte Biologics, together the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry, today announced the launch of an IRB-approved initiative to support the research, therapeutic, and vaccine communities

In response to both public and private interest, LifeNome has developed the COVID-19 SPARE (Severity Predisposition Assessment and Risk Evaluation) product. SPARE provides individuals with information and a risk assessment of their potential risk of a severe COVID infection

Athersys, Inc. (NASDAQ: ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the Bank of America Merrill Lynch 2020 Virtual Healthcare Conference to investors and analysts.

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has received a No Objection Letter from Health Canada to proceed with a NP-120 (Ifenprodil) COVID-19 Phase 2b/3 multinational clinical trial.

Community-based 3D printing makers mobilize to solve PPE shortage, helping protect police, fire and rescue, and other critical essential service providers from COVID-19 virus

Intense Engineering proudly introduces the HSP-1000. Precision engineered, purpose-built, and based on their proven clinical/diagnostic equipment platform, the fully automated HSP-1000 brings speed, safety, and accuracy to COVID-19 sample tube testing.

OrthoPediatrics Corp. announced that Mark Throdahl, President & Chief Executive Officer, Fred Hite, Chief Financial Officer, and Dave Bailey, Executive Vice President, are scheduled to participate in the 6th Annual SunTrust Robinson Humphrey Life Sciences Summit Virtual Series.